Nabi Biopharmaceuticals
Return to Library
Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference
2009 JUL 27 - (NewsRx.com) -- Jesup & Lamont, Inc., (AMEX: JLI), a full-service boutique brokerage and investment banking firm serving retail and institutional clients, announced the LifeTech Capital Group companies presenting at its 2009 Growth Stock & National Sales Conference to be held at the Waldorf Astoria Boca Beach Club on July 30th, 2009 in Boca Raton, Florida. In addition, former FDA Commissioner Dr. Lester M. Crawford D.V.M., Ph.D., will be the keynote speaker for the event. "As large pharmaceutical companies continue to struggle with patent expirations, pricing pressures, R&D cuts and changes to the U.S. healthcare system, we believe smaller biotech companies represent an exciting source of value-creation for investors," says Stephen M. Dunn, Managing Director of Life Sciences Research at LifeTech Capital Group. "With the government's recent demands for comparative effectiveness of drugs, there is a corresponding increase in demand for companies with novel, breakthrough approaches. We're pleased to have such a diversified group of innovative biotech companies presenting at our conference." Some of the companies presenting on July 30th include Peregrine Pharmaceuticals (NASDAQ:PPHM), Cytori Therapeutics (NASDAQ:CYTX), NovaBay Pharmaceuticals (AMEX:NBY), Nabi Biopharmaceuticals (NASDAQ:NABI), OXiGENE Inc. (NASDAQ:OXGN), Access Pharmaceuticals (BULLETIN BOARD: ACCP) , Echo Therapeutics (BULLETIN BOARD: ECTE) , Raptor Pharmaceuticals (OTC Bulletin Board: RPTP), Neoprobe Corp. (BULLETIN BOARD: NEOP) and Oxygen Biotherapeutics (BULLETIN BOARD: OXBO) . Jesup's annual conference provides its clients a distinctive forum in which to visit with and hear presentations from unique growth companies in the life sciences, healthcare, aerospace and transportation industries. The conference commences with Life Science industry and investor panels on Wednesday July 29th with Company presentations on Thursday July 30th, followed by Investment Products presentations on August 1st and 2nd. Last year's conference brought together hundreds of institutional and retail investors in an intimate format. For more information or registration to present or attend, contact your Jesup salesperson, Donald A. Wojnowski at dwojnowski@jesuplamont.com or Tammy Kraus at tkraus@jesuplamont.com. You can also register online at www.jesuplamontconferences.com. Keywords: FDA, Patent Actions, Patents Actions, Peregrine Pharmaceuticals, Pharmaceutical Business, Pharmaceutical Company, U.S. Food and Drug Administration, Jesup & Lamont Inc. This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business Week via NewsRx.com.
|
